Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BTCYNASDAQ:INVONASDAQ:NURONYSE:RMED On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBTCYBiotricity$0.42+7.7%$0.48$0.19▼$1.01$10.47M1.1136,770 shs21,500 shsINVOINVO Bioscience$0.86-1.3%$1.60$0.63▼$3.50$3.29M1.431.59 million shs54,365 shsNURONeuroMetrix$4.55+4.4%$4.54$2.66▼$4.73$9.37M1.8216,608 shs35,522 shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shs2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBTCYBiotricity0.00%+4.48%-19.98%+36.62%-45.13%INVOINVO Bioscience0.00%-5.86%-42.01%-52.79%+10.77%NURONeuroMetrix0.00%0.00%0.00%+3.88%+22.97%RMEDRa Medical Systems0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBTCYBiotricityN/AN/AN/AN/AN/AN/AN/AN/AINVOINVO BioscienceN/AN/AN/AN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBTCYBiotricity 2.00HoldN/AN/AINVOINVO Bioscience 0.00N/AN/AN/ANURONeuroMetrix 0.00N/AN/AN/ARMEDRa Medical Systems 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBTCYBiotricity$12.06M0.87N/AN/A($1.30) per share-0.32INVOINVO Bioscience$5.77M0.57N/AN/A($2.06) per share-0.42NURONeuroMetrix$3.03M3.09N/AN/A$13.18 per share0.35RMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBTCYBiotricity-$14.09M-$1.08N/A∞N/A-80.42%N/A-188.47%8/18/2025 (Estimated)INVOINVO Bioscience-$8.03MN/A0.00∞N/A-122.79%N/A-36.94%N/ANURONeuroMetrix-$6.53M-$4.59N/A∞N/A-203.71%-42.56%-39.26%8/4/2025 (Estimated)RMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBTCYBiotricityN/AN/AN/AN/AN/AINVOINVO BioscienceN/AN/AN/AN/AN/ANURONeuroMetrixN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBTCYBiotricityN/A0.230.10INVOINVO BioscienceN/A0.300.27NURONeuroMetrixN/A13.8812.70RMEDRa Medical SystemsN/A2.862.85Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBTCYBiotricity3.89%INVOINVO Bioscience12.02%NURONeuroMetrix19.40%RMEDRa Medical Systems11.00%Insider OwnershipCompanyInsider OwnershipBTCYBiotricity10.10%INVOINVO Bioscience3.50%NURONeuroMetrix7.30%RMEDRa Medical Systems18.62%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBTCYBiotricity4024.91 million22.08 millionOptionableINVOINVO Bioscience253.81 million3.77 millionNo DataNURONeuroMetrix202.06 million1.90 millionNot OptionableRMEDRa Medical Systems145.37 million4.37 millionNot OptionableRMED, NURO, BTCY, and INVO HeadlinesRecent News About These CompaniesSetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024November 19, 2024 | businesswire.comIntercorp Financial Servs (NYSE:IFS) Stock Quotes, Forecast and News SummaryOctober 20, 2024 | benzinga.comRA Activity and Disease Control Assessment via Telehealth MetricsOctober 11, 2024 | physiciansweekly.comPMedical device maker, physicians, to pay $8M+ in kickback schemeSeptember 28, 2024 | beckersasc.comBCT-based radiomics nomogram can ID RA-linked interstitial lung diseaseSeptember 6, 2024 | medicalxpress.comMRa Medical Systems Inc (4RM.BE)August 18, 2024 | uk.finance.yahoo.comChina Medical System: NDA for Additional Rheumatoid Arthritis Indication of Methotrexate Injection Approved in ChinaAugust 6, 2024 | markets.businessinsider.comIn RA Treatment, Don't Overlook Underlying CV RisksMay 16, 2024 | medscape.comMMercy Medical Center Dr. Wright discusses Rheumatoid Arthritis in womenApril 28, 2024 | wbaltv.comWDietary Interventions Reduce CVD Risk in RA and SpAMarch 8, 2024 | ajmc.comAAlert1 Medical Alert System Review: What Experts Say (2024)February 20, 2024 | forbes.comRa Medical Systems Inc.February 15, 2024 | thestreet.comCatheter Precision Inc (VTAK)February 11, 2024 | investing.comVTAK Catheter Precision, Inc.January 19, 2024 | seekingalpha.comWhat Is The Life Expectancy Of Rheumatoid Arthritis? A Review By DoctorsJanuary 7, 2024 | msn.comCatheter Precision Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QAugust 25, 2023 | finance.yahoo.comReminder: Ra Medical Systems Announces Name and Ticker Symbol ChangesAugust 17, 2023 | finance.yahoo.comRa Medical Systems, Inc.: Ra Medical Systems Announces Allowance of New Closure Device PatentAugust 16, 2023 | finanznachrichten.deRa Medical Systems Announces Milestone Achievement for Electrophysiology DivisionAugust 7, 2023 | finance.yahoo.comRa Medical Systems, Inc.: Ra Medical Systems Announces Proposed Name and Ticker Symbol ChangesAugust 2, 2023 | finanznachrichten.deMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir SoonIPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBy Dan Schmidt | June 20, 2025View IPO Momentum Returns: 3 Stocks Rising After CoreWeave’s SurgeBigBear.ai Poised to Benefit as Palantir Dominates AI DefenseBy Gabriel Osorio-Mazilli | June 23, 2025View BigBear.ai Poised to Benefit as Palantir Dominates AI DefenseAeroVironment Will Hit New Highs This Year: Bull Flag ConfirmedBy Thomas Hughes | June 25, 2025View AeroVironment Will Hit New Highs This Year: Bull Flag ConfirmedBreakout Alert: Disney Stock Hits Multi-Year HighBy Sam Quirke | July 1, 2025View Breakout Alert: Disney Stock Hits Multi-Year HighRMED, NURO, BTCY, and INVO Company DescriptionsBiotricity NASDAQ:BTCY$0.42 +0.03 (+7.72%) As of 07/3/2025 12:01 PM EasternBiotricity, Inc., a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.INVO Bioscience NASDAQ:INVO$0.86 -0.01 (-1.31%) As of 07/3/2025INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The company was founded in 2007 and is based in Sarasota, Florida.NeuroMetrix NASDAQ:NURO$4.55 +0.19 (+4.36%) Closing price 05/1/2025Extended Trading$4.55 0.00 (0.00%) As of 05/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use. The company offers its products to managed care organizations, endocrinologists, podiatrists, and primary care physicians; occupational health, primary care, internal medicine, orthopedic, and hand surgeons; and pain medicine physicians, neurologists, physical medicine and rehabilitation physicians, and neurosurgeons. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.Ra Medical Systems NYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
